Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
akouos
2
×
alnylam pharmaceuticals
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
sickle cell disease
texas blog main
texas top stories
venture capital
vir biotechnology
wisconsin blog main
wisconsin top stories
abbvie
abeona therapeutics
accent therapeutics
achilles therapeutics
alder biopharmaceuticals
alexion pharmaceuticals
What
bio
2
×
roundup
acquisitions
advantages
announced
bar
brings
ceo
collabs
covid
daniel
deal
drug
expect
gamble
gilead
gilead’s
help
introduce
ipo
market
medco’s
medicines
month
mover
new
o’day
patients
payers
physicians
plan
plans
pricing
sciences
sets
transformative
type
ubiome
undone
vertex’s
Language
unset
Current search:
akouos
×
bio
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
